(Q93608026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

title

Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

main subject

phase II clinical trial

1 reference

1 reference

1 reference

1 reference

D J Wagener

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

S H Yap

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

T Wobbes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

J T Burghouts

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

F E van Dam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

H F Hillen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

G J Hoogendoorn

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

H Scheerder

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

S G van der Vegt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

8 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

page(s)

86-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

Clinical management of advanced gastrointestinal cancer

8 May 2020

cites work

1 reference

12 December 2020

A comparative clinical assessment of combination chemotherapy in the management of advanced gastric carcinoma: The Gastrointestinal Tumor study Group

1 reference

12 December 2020

Improved combination chemotherapy in advanced gastric cancer

1 reference

12 December 2020

Sequential and combination chemotherapy of advanced gastric cancer

1 reference

12 December 2020

5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer

1 reference

12 December 2020

Phase II-III chemotherapy studies in advanced gastric cancer. Eastern Cooperative Oncology Group

1 reference

12 December 2020

Cisplatin.An active drug in the treatment of disseminated gastric cancer

1 reference

12 December 2020

Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00257302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4039985%20AND%20SRC:MED&resulttype=core&format=json

8 May 2020

1 reference